Immunology, Microbiology & Inflammatory Bowel Diseases
Members interested in participating in the activities of the AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases Section should contact us at [email protected]. We are especially interested in increasing participation of junior investigators, clinicians and international members.
Mission Statement and FOCI
The AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases Section (IMIBD) executes AGA’s strategic plan by providing an international forum to present and evaluate the most exciting and innovative research in the field. By providing a forum for debate, collaboration and an exchange of ideas, the IMIBD section helps define what is state-of-the-art care in IBD and pushes the boundaries of science in search of a cure. Established and emerging leaders collate this information to provide education and training to both the next generation of researchers as well as for providers caring for patients with IBD. This enhanced knowledge leads to improved practice and quality, ultimately showing the value of section through the work of its diverse members.
Areas of focus
The section presently has identified 18 specific areas of active and current foci, which are:
- Clinical research in IBD
- Clinical management related to IBD
- Basic and translational research related to IBD
- Research topics include but are not limited to:
- Immunology
- Microbiome
- Epidemiology
- Cancer epidemiology
- Novel therapy (mouse models and human)
- Optimizing existing therapy
- Disease and therapy-related adverse events
- Diagnostics and imaging
- Epidemiology
- Diet and environment
Council Leadership
FERNANDO VELAYOS, MD, AGAF
Chair
UCSF School of Medicine
ASHWIN ANANTHAKRISHNAN, MPH, MBBS
Vice Chair
Massachusetts General Hospital
